Pyloric sphincter therapy: Botulinum toxin, stents, and pyloromyotomy

John O. Clarke, William J. Snape

Research output: Contribution to journalReview articlepeer-review

Abstract

Gastroparesis is a syndrome characterized by delayed gastric emptying with associated symptoms. Gastric emptying is a complex process and pyloric dysfunction may play a key role in select subsets of patients with gastroparesis. Diagnostic tests to measure pyloric physiology are now available and have the potential to be more widely used in clinical practice. Targeted therapies including botulinum toxin, transpyloric stent placement, surgical pyloroplasty and endoscopic pyloromyotomy have been developed. Data are emerging regarding efficacy and durability, but these therapies may play a prominent role in select patients with gastroparesis and pyloric dysfunction.

Original languageEnglish (US)
Pages (from-to)127-136
Number of pages10
JournalGastroenterology Clinics of North America
Volume44
Issue number1
DOIs
StatePublished - Mar 1 2015

Keywords

  • Botulinum toxin
  • Gastroparesis
  • Impedance planimetry
  • Pyloric stent
  • Pyloromyotomy
  • Pyloroplasty

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint Dive into the research topics of 'Pyloric sphincter therapy: Botulinum toxin, stents, and pyloromyotomy'. Together they form a unique fingerprint.

Cite this